trending Market Intelligence /marketintelligence/en/news-insights/trending/iKywp9RxB-I-9X45D40XsQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Delcath Systems plans 1-for-100 reverse stock split

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Delcath Systems plans 1-for-100 reverse stock split

Delcath Systems Inc. said its board authorized a reverse stock split of the company's common stock at a ratio of 1-for-100.

The proposal for the stock split was approved by shareholders Sept. 17. The action will reduce the number of Delcath's issued and outstanding shares, as well as those reserved for issuance, to about 14 million from about 1.4 billion.

Starting Oct. 22, Delcath's shares will be designated by the symbol DCTHD for 20 trading days, after which the shares will be found under the DCTH symbol. The common stock will be assigned a new CUSIP number of 24661P 807 following the reverse stock split.

American Stock Transfer & Trust Co. is acting as the exchange agent and transfer agent for the reverse stock split.

New York-based Delcath Systems is a healthcare equipment company focusing on the treatment of primary and metastatic liver cancers. Its investigational products include melphalan hydrochloride for injection, which used to administer high-dose chemotherapy to the liver.